Medical News
Clinical research, biomedical innovations and clinical trials
New Insights into the Mechanism of Brain Cell Death in Alzheimer's Disease
Researchers have identified a novel process called karyoptosis that may unravel how brain cells perish in Alzheimer's and frontotemporal dementia.
New Insights into Cognitive Resilience Against Alzheimer’s Disease
Research reveals how certain brain cells contribute to cognitive resilience in Alzheimer's patients, paving the way for future therapeutic strategies.
Reassessing Lacunar Stroke: New Insights on Small Vessel Disease
Emerging research reveals small vessel disease as the primary cause of lacunar stroke, challenging traditional preventive treatment approaches.
New Insights into Alzheimer’s Disease: Arc Protein’s Role in Tau Transmission
Recent research reveals that the Arc protein facilitates the spread of toxic Tau in Alzheimer's, suggesting new avenues for treatment strategies.
New Tool for Assessing Statin Risks Aims to Inform Patient Treatment Decisions
A newly developed calculator from Oxford University helps patients and doctors evaluate the risks of serious muscle disorders when using statins.
Understanding the Threats of Ebola and Hantavirus: Symptoms, Risks, and Management
Ebola and hantavirus pose significant health risks, sharing similar early symptoms but differing in transmission and treatment strategies.
Research Highlights Tubulin's Key Role in Mitigating Toxic Protein Aggregation in Neurodegenerative Diseases
Baylor College of Medicine's research reveals tubulin's potential to redirect harmful proteins in the brain, offering insights for Alzheimer's and Parkinson's therapies.
Significant Cognitive and Physical Gains in Older Adults, Yale Study Reveals
Yale research shows many older adults experience notable cognitive and physical improvements, challenging common perceptions of aging.
New Research Uncovers Pain-Relief Potential of Cannabis Terpenes Without THC's Psychoactive Effects
Researchers discover that terpenes from cannabis can alleviate chronic pain, such as fibromyalgia and post-surgical discomfort, without psychoactive effects.
New Compound Offers Hope for Restoring Brain Immunity Against Alzheimer’s Disease
A novel molecule, OLE, has shown potential in reversing microglial impairment linked to Alzheimer's, enhancing their ability to combat beta-amyloid plaques.
New Insights Into Alzheimer's: The Role of Protein Interference
A recent study suggests Alzheimer's may begin with protein interactions disrupting cellular processes, challenging long-held beliefs about amyloid beta.
Understanding the Connection Between Diabetes and Dementia
Research links diabetes and dementia, revealing how glucose regulation impacts cognitive health and opens doors for potential treatment approaches.
Research Reveals Patterns in GLP-1 Medication Use Among Type 2 Diabetes Patients
New findings from a study show significant patterns in the stoppage and restart of GLP-1 medications among Type 2 diabetes patients.
Monash University Researchers Uncover Copper Compound’s Potential in Alzheimer’s Treatment
New findings suggest a copper-based drug may enhance waste removal in the brain, reducing toxic proteins associated with Alzheimer's and improving memory.
New Research Links Cancer Mutations in Microglia to Alzheimer's Disease Development
A study reveals that cancer-related mutations in microglia may play a significant role in Alzheimer's disease progression, opening potential for new diagnostic approaches.
Link Between Glucosamine Use and Accelerated Alzheimer’s Disease Progression
Recent research indicates that glucosamine supplements may accelerate dementia progression in individuals with mild cognitive impairment.
New Insights on Alzheimer's: ETH Zurich Researchers Uncover a Targeting Protein and a Novel Treatment
ETH Zurich's research identifies GRK2 as a key player in Alzheimer's and introduces Compound 10, a potential new treatment that reduces nerve cell loss.
Research Links GLP-1 Weight-Loss Medications to Reduced Breast Cancer Risk in Women
New research indicates that GLP-1 medications like Ozempic and Wegovy may lower breast cancer risk by 30%, urging further investigation into their potential as preventive tools.
Genetic Factors Impacting the Effectiveness of GLP-1 Medications in Diabetes Treatment
New research highlights how genetic variants may prevent some patients from responding effectively to GLP-1 agonists like Ozempic, emphasizing the need for precision medicine.
New Insights on GLP-1 Medications: Potential to Combat Addiction Alongside Obesity
Research suggests GLP-1 medications may reduce addiction risks and improve treatment outcomes, opening avenues for dual-use in obesity and substance disorders.